Fig. 1.
Fig. 1. Tyrosine phosphorylation of Vav1. / (A-B) Human platelets were stimulated with CRP (1 μg/mL) as shown in (A) or with thrombin (thr; 1 U/mL) as shown in (B), and lysis buffer added at the indicated time point. Vav1 was immunoprecipitated from these samples and analyzed by immunoblotting with monoclonal antiphosphotyrosine antibody 4G10 (anti–p-Tyr). Immunoblots were then stripped and reprobed with an antibody to Vav1 (lower panel). (C) Human platelets were incubated with the PI 3-kinase inhibitors, wortmannin, or Ly294002, or the Src kinase inhibitor PP1, as described in “Materials and methods.” (D) CRP (1 μg/mL)–induced tyrosine phosphorylation of Vav1 in platelets from mice deficient in the tyrosine kinase Syk were analyzed at the indicated time points as described above.

Tyrosine phosphorylation of Vav1.

(A-B) Human platelets were stimulated with CRP (1 μg/mL) as shown in (A) or with thrombin (thr; 1 U/mL) as shown in (B), and lysis buffer added at the indicated time point. Vav1 was immunoprecipitated from these samples and analyzed by immunoblotting with monoclonal antiphosphotyrosine antibody 4G10 (anti–p-Tyr). Immunoblots were then stripped and reprobed with an antibody to Vav1 (lower panel). (C) Human platelets were incubated with the PI 3-kinase inhibitors, wortmannin, or Ly294002, or the Src kinase inhibitor PP1, as described in “Materials and methods.” (D) CRP (1 μg/mL)–induced tyrosine phosphorylation of Vav1 in platelets from mice deficient in the tyrosine kinase Syk were analyzed at the indicated time points as described above.

Close Modal

or Create an Account

Close Modal
Close Modal